Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01984892 · ClinicalTrials.gov registry record · Phase 2
Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
A Phase 2 study, sponsored by Nina Bhardwaj.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT01984892: Clinical Trial Phase 2 study, sponsored by Nina Bhardwaj.
NCT01984892 is a Phase 2 study that was terminated before completion, run by Nina Bhardwaj. The registered enrollment target is 8 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01984892, a Phase 2 study, was terminated before completion, sponsored by Nina Bhardwaj.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety of a course of injections containing Poly-ICLC in patients with advanced solid tumors that can be easily and safely reached with a needle. Poly-ICLC is a compound that has been used to help the body in its fight against cancer.
Primary Outcome
Progression-free survival defined as the time in weeks from study entry until tumor progression defined using the Wolchok criteria or death. Patients who are alive and free from progression on the date of closing follow-up will be censored on that date. In order to minimize the potential for misdiagnosis of pseudoprogression, related to early inflammation, tumor measurement for determination of progression will be made at the earliest at 26 weeks.
Interventions
- DRUG Poly-ICLC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
Why NCT01984892 stopped before completion
NCT01984892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Poly-ICLC is the first listed.
NCT01984892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01984892 about?
NCT01984892 is a clinical study titled "Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)". The purpose of this study is to test the safety of a course of injections containing Poly-ICLC in patients with advanced solid tumors that can be easily and safely reached with a needle. Poly-ICLC is a compound that has been used to help the body in its fight against cancer.
What is the current status of trial NCT01984892?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2013-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01984892?
The interventions under investigation include: Poly-ICLC (DRUG).
Who is sponsoring clinical trial NCT01984892?
This trial is sponsored by Nina Bhardwaj, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01984892's enrollment target sits among peer trials
8 1990th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia